Delivery Order SPE2DB20D3103-SPE2DB25FN7Y5
Award Date
5/13/25
Potential Completion Date
6/4/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ENVARSUS XR 0.75 MG tablets to the Defense Logistics Agency (DLA). The $1,141.80 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 18, 2024 and was awarded on November 26, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
The federal contract award is for the provision of ENVARSUS XR 4 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 18, 2025, with a completion date of April 8, 2025. The contract has a ceiling value of $3,423.90 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This federal contract award is for the delivery of ENVARSUS XR 1 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The $1,216.11 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has an ultimate completion date of August 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,288.86 and a completion date of March 26, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation indicated. The contract is part of a larger Indefinite...
This federal contract award is for the procurement of ENVARSUS XR 1 MG TABLET 30S, a pharmaceutical product, by the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,165.05 and an ultimate completion date of March 6, 2025. The contract does not have a set-aside designation, indicating open competition....
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of ENVARSUS XR 1 MG TABLET 30S, a pharmaceutical product, to the government. The fixed-price delivery order has a ceiling value of $1,165.05 and a performance period ending on June 5, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and is open to competition. Amerisourcebergen Drug Corp also holds...
This federal contract award is for the delivery of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $6,684.64 and is a Firm Fixed Price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through December 18, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $1,288.86. The contract has an ultimate completion date of June 9, 2025 and was awarded on May 16, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,577.72, is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price of $1,718.48 and a completion date of June 11, 2025. The contract is not set aside and was awarded on May 20, 2025. Amerisourcebergen Drug Corp is the prime contractor and this award is...